Zobrazeno 1 - 10
of 181
pro vyhledávání: '"cardiovascular injury"'
Publikováno v:
Cardiovascular & Hematological Agents in Medicinal Chemistry. 20:133-147
Background: Diabetic cardiotoxicity is commonly associated with oxidative injury, inflammation, and endothelial dysfunction. L-ergothioneine (L-egt), a diet-derived amino acid, has been reported to decrease mortality and risk of cardiovascular injury
Autor:
Sadeer G. Al-Kindi, David A. Zidar
Publikováno v:
Translational Research
Early in the pandemic, concern that cardiovascular effects would accompany COVID-19 was fueled by lessons from the first SARS epidemic, knowledge that the SARS-COV2 entry receptor (Angiotensin-converting enzyme 2, ACE2) is highly expressed in the hea
Publikováno v:
Chinese Medical Journal. 135:1019-1026
Hypertension is the leading risk factor for global mortality and morbidity and those with hypertension are more likely to develop severe symptoms in cardiovascular and cerebrovascular system, which is closely related to abnormal renin-angiotensin sys
Autor:
Hongqin Yang, Chi Geng, Zhiwei Li, Yaqin Tang, Hongmei Zhao, Jing Wang, Yu-Fan Feng, Pei-Ran Yang, Cui-Liu Hou
Publikováno v:
Acta Pharmacol Sin
Cardiovascular disease is a common comorbidity in patients with cancer, and the main leading cause of noncancer-related deaths in cancer survivors. Considering that current antitumor drugs usually induce cardiovascular injury, the quest for developin
Publikováno v:
Journal of Pharmaceutical Investigation. 51:337-346
Polypharmacy is an important strategy for managing high blood pressure (BP). Combination treatment with a Ca2+ channel blocker (CCB) and an angiotensin II type 1 receptor blocker (ARB) can be used for this purpose. If combination therapy had addition
Autor:
Victoria Kwiat, Michelle S. Parvatiyar, Joachim J. Bugert, Isela C. Valera, Christina L Bugert
Publikováno v:
Current Clinical Microbiology Reports
Purpose of Review The world is currently facing the largest global health crisis since the early 1900s due to a novel coronavirus. While SARS-CoV-2 infection causes predictable symptoms in COVID-19 patients, including upper respiratory distress and f
Autor:
S. G. Kanorskii
Publikováno v:
Кубанский научный медицинский вестник, Vol 28, Iss 1, Pp 16-31 (2021)
Background. The pandemic of severe acute respiratory syndrome COVID-19 drew the attention of researchers and practitioners worldwide to severe cardiovascular injury incurred by the new SARS-CoV-2 coronavirus. Objectives . A review and structuring of
Publikováno v:
Cardiology Research
First documented in China in early December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly and continues to test the strength of healthcare systems and public health programs all over the world. Underlying
Publikováno v:
Melatonin Research. 4:1-29
The onset and progression of baneful chronic diseases are often accompanied by a torrent of uncontrolled inflammatory reactions. Although inflammation is a natural response to detect, eliminate, and counterpoise the harmful insults to physiological i
Autor:
Louis J. Dell'Italia, Joseph A. Murray, Matthew A. Sparks, Janani Rangaswami, Scott E. Kasner, Carissa M. Baker-Smith, Biykem Bozkurt, Kathy Griendling, W. Robert Taylor, Andrew D. Badley, Daniel Batlle, Susan B. Gurley, Roberto Cattaneo, Marc A. Pfeffer, Andrew M South, Andria L. Ford, Karl A. Nath, Steven D. Crowley, Vesna D. Garovic
Publikováno v:
Hypertension
The coronavirus disease 2019 (COVID-19) pandemic is associated with significant morbidity and mortality throughout the world, predominantly due to lung and cardiovascular injury. The virus responsible for COVID-19—severe acute respiratory syndrome